Sutcliffe JL - Search Results

1

High-Throughput Approaches to the Development of Molecular Imaging Agents.

Hu LY, Kelly KA, Sutcliffe JL. Hu LY, et al. Among authors: sutcliffe jl. Mol Imaging Biol. 2017 Apr;19(2):163-182. doi: 10.1007/s11307-016-1016-z. Mol Imaging Biol. 2017. PMID: 27812924 Review.

2

From combinatorial chemistry to cancer-targeting peptides.

Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS. Aina OH, et al. Among authors: sutcliffe jl. Mol Pharm. 2007 Sep-Oct;4(5):631-51. doi: 10.1021/mp700073y. Epub 2007 Sep 20. Mol Pharm. 2007. PMID: 17880166 Review.

3

Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts.

Martin SM, O'Donnell RT, Kukis DL, Abbey CK, McKnight H, Sutcliffe JL, Tuscano JM. Martin SM, et al. Among authors: sutcliffe jl. Mol Imaging Biol. 2009 Mar-Apr;11(2):79-87. doi: 10.1007/s11307-008-0148-1. Epub 2008 Oct 24. Mol Imaging Biol. 2009. PMID: 18949521

4

Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.

Hausner SH, Kukis DL, Gagnon MK, Stanecki CE, Ferdani R, Marshall JF, Anderson CJ, Sutcliffe JL. Hausner SH, et al. Among authors: sutcliffe jl. Mol Imaging. 2009 Mar-Apr;8(2):111-21. Mol Imaging. 2009. PMID: 19397856 Free PMC article.

5

High-throughput in vivo screening of targeted molecular imaging agents.

Gagnon MK, Hausner SH, Marik J, Abbey CK, Marshall JF, Sutcliffe JL. Gagnon MK, et al. Among authors: sutcliffe jl. Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17904-9. doi: 10.1073/pnas.0906925106. Epub 2009 Oct 7. Proc Natl Acad Sci U S A. 2009. PMID: 19815497 Free PMC article.

6

Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6.

Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. Hu LY, et al. Among authors: sutcliffe jl. Mol Imaging Biol. 2014 Aug;16(4):567-77. doi: 10.1007/s11307-013-0717-9. Mol Imaging Biol. 2014. PMID: 24448825 Free PMC article.

7

The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.

Hausner SH, Bauer N, Hu LY, Knight LM, Sutcliffe JL. Hausner SH, et al. Among authors: sutcliffe jl. J Nucl Med. 2015 May;56(5):784-90. doi: 10.2967/jnumed.114.150680. Epub 2015 Mar 26. J Nucl Med. 2015. PMID: 25814519 Free PMC article.

8

WIMIN: Who We Are and What We Do.

Moore A, Menkens A, Sutcliffe J. Moore A, et al. Mol Imaging Biol. 2017 Jun;19(3):328-331. doi: 10.1007/s11307-017-1059-9. Mol Imaging Biol. 2017. PMID: 28255841

9

ImmunoPET Imaging of α_vβ₆ Expression Using an Engineered Anti-α_vβ₆ Cys-diabody Site-Specifically Radiolabeled with Cu-64: Considerations for Optimal Imaging with Antibody Fragments.

White JB, Hu LY, Boucher DL, Sutcliffe JL. White JB, et al. Among authors: sutcliffe jl. Mol Imaging Biol. 2018 Feb;20(1):103-113. doi: 10.1007/s11307-017-1097-3. Mol Imaging Biol. 2018. PMID: 28653240

10

Identification, Characterization, and Optimization of Integrin α_vβ₆-Targeting Peptides from a One-Bead One-Compound (OBOC) Library: Towards the Development of Positron Emission Tomography (PET) Imaging Agents.

Tang YSC, Davis RA, Ganguly T, Sutcliffe JL. Tang YSC, et al. Among authors: sutcliffe jl. Molecules. 2019 Jan 16;24(2):309. doi: 10.3390/molecules24020309. Molecules. 2019. PMID: 30654483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page